Atlas Trials

Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora Colonisation

Clinical trial NCT02730494 · COMPLETED

Trial details

NCT number
NCT02730494
Sponsor
Biose
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Candidiasis, Vulvovaginal
Start date
2015-07-01
Primary completion
2016-01-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.